샘플 요청 목록

 카트 문의
시장보고서
상품코드
2156125

혈액은행 및 혈액제제 시장

Blood Banking and Blood Products
발행일: | 리서치사: 구분자 Market Glass, Inc. | 페이지 정보: 영문 548 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



가격
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 파일 내 텍스트의 복사 및 붙여넣기는 가능하지만, 표/그래프 등은 복사할 수 없습니다. 인쇄는 1회 가능하며, 인쇄물의 이용범위는 파일 이용범위와 동일합니다.
US $ 5,850 금액 안내 화살표 ￦ 7,953,000
PDF & Excel (Team License: Up to 10 users) help
PDF & Excel 보고서를 동일 기업 내 최대 10명까지 이용할 수 있는 라이선스입니다. 파일 내 텍스트의 복사 및 붙여넣기가 가능하지만, 표/그래프 등은 복사할 수 없습니다. 인쇄는 이용자 1명당 1회 가능하며, 인쇄물의 이용범위는 파일 이용범위와 동일합니다.
US $ 11,115 금액 안내 화살표 ￦ 15,110,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel 보고서를 동일 기업 및 100% 자회사의 모든 분이 이용하실 수 있는 라이선스입니다. 인쇄는 1인당 1회 가능하며, 인쇄물의 이용범위는 파일 이용범위와 동일합니다.
US $ 17,550 금액 안내 화살표 ￦ 23,859,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 혈액은행 및 혈액제제 시장은 2032년까지 427억 달러에 달할 것으로 전망됩니다.

2025년 336억 달러로 추산되는 세계 혈액은행 및 혈액제제 시장은 2025-2032년의 분석 기간 동안 연평균 성장률(CAGR) 3.5%를 기록하며, 2032년까지 427억 달러에 달할 것으로 예측됩니다. 본 보고서에서 분석 대상으로 다루고 있는 부문 중 하나인 ‘혈장 유래 치료제’는 연평균 성장률(CAGR) 2.7%를 기록하며, 분석 기간이 끝날 때까지 260억 달러에 달할 것으로 예측됩니다. ‘전혈 및 혈액 성분’ 부문의 성장률은 분석 기간 동안 연평균 성장률(CAGR) 4.8%를 나타낼 것으로 추정됩니다.

미국 시장은 92억 달러로 추산되는 반면, 중국은 연평균 성장률(CAGR) 5.9%를 나타낼 것으로 예측됩니다.

미국의 혈액은행 및 혈액제제 시장은 2025년에 92억 달러로 추산됩니다. 세계 2위의 경제 규모를 자랑하는 중국은 2025-2032년의 분석 기간 동안 연평균 성장률(CAGR) 5.9%를 기록하며, 2032년까지 시장 규모가 84억 달러에 달할 것으로 예측됩니다. 그 밖의 주목할 만한 지역 시장으로는 일본과 캐나다가 꼽히며, 분석 기간 동안 각각 연평균 성장률(CAGR) 1.6% 및 2.7%를 나타낼 것으로 예측됩니다. 유럽 내에서는 독일이 연평균 성장률(CAGR) 약 2.2%를 나타낼 것으로 예측됩니다.

세계 혈액은행 및 혈액제제 시장 - 주요 동향 및 촉진요인 개요

혈액은행 시스템은 공중보건을 어떻게 뒷받침하고 있는가?

현대 의료 시스템에서 필수적인 요소인 혈액은행은 의료 처치에 필요한 혈액 및 혈액 제제의 안전한 채취, 보존, 공급을 보장합니다. 이 시스템에는 기증자로부터 전혈을 채취하는 것뿐만 아니라, 적혈구, 혈소판, 혈장 등의 성분을 추출하기 위한 혈액 처리도 포함되어 있으며, 이러한 성분들은 개별적으로 다양한 질병의 치료에 사용됩니다. 수혈을 통해 감염될 위험을 최소화하고 혈액 제제의 안전성과 유효성을 확보하기 위해, 과정의 모든 단계가 엄격한 규제 기준에 따라 관리되고 있습니다. 또한, 혈액은행은 일상적인 수요나 위기 상황에 따른 수요에 대응할 수 있도록 충분한 공급량을 유지함으로써, 비상사태에 대비하는 데에도 매우 중요한 역할을 수행하고 있습니다. 헌혈자 모집부터 의료시설로의 혈액 제제 최종 배송에 이르는 공급망을 관리하는 혈액은행의 효율성은 인명을 구하고 환자의 예후를 개선하는 능력에 직접적인 영향을 미칩니다.

혈액은행을 발전시키고 있는 기술 혁신은 무엇일까？

혈액은행 분야는 혈액 제제의 보존 및 수혈의 안전성, 효율성, 유효성을 높이는 기술의 발전으로부터 막대한 혜택을 받고 있습니다. 채혈 및 처리 자동화 시스템 덕분에 많은 절차가 표준화되었고, 인적 오류가 감소했으며, 이용 가능한 혈액 성분의 수율이 향상되었습니다. 병원체 제거 시스템과 같은 기술은 감염증을 유발할 수 있는 오염 물질을 불활성화함으로써 수혈의 안전성을 높이고 있습니다. 또한, 첨단 냉장·냉동 설비 덕분에 혈액 제제의 보존 기간이 연장되어 재고 관리가 개선되고 폐기물이 감소하게 되었습니다. 데이터 관리 시스템은 이러한 기술을 통합하여 실시간 추적 및 최적화된 물류를 제공함으로써, 가장 필요한 시기와 장소에서 적절한 유형의 혈액 제제가 확실하게 이용될 수 있도록 하고 있습니다.

규제 변경과 세계적인 보건 수요는 혈액은행에 어떤 영향을 미치고 있는가?

규제 체계와 세계적인 보건 수요는 혈액은행 업계의 실무를 끊임없이 형성하고 있습니다. 규제 변경은 많은 경우 의학 연구의 진보, 새로운 건강 위협, 혹은 공중보건 정책의 전환을 반영합니다. 예를 들어, 세계적인 팬데믹이나 감염병 유행에 대응할 때는 혈액 공급을 확보하기 위해 채혈 방법이나 헌혈자 자격 기준을 신속하게 조정해야 합니다. 또한, 국제적인 협력 노력을 통해 세계의 운영 기준이 향상되고 있으며, 자원이 부족한 지역의 혈액 안전성과 공급량 증대를 목표로 하고 있습니다. 이러한 노력에는 교육, 표준화된 프로토콜 수립, 혈액은행 인프라 구축 지원 등이 포함되며, 이는 세계 의료 격차 해소와 생명을 구하는 혈액 제제에 대한 공평한 접근을 보장하는 데 필수적입니다.

혈액은행 및 혈액제제 시장의 성장을 견인하는 요인은 무엇일까？

혈액은행 및 혈액제제 시장의 성장은 기술 발전, 헌혈의 중요성에 대한 인식 제고, 세계 의료 수요 증가 등 여러 요인에 의해 주도되고 있습니다. 채혈, 처리, 보존의 효율을 높이는 기술 혁신은 혈액 공급의 전반적인 안전성과 안정성을 강화하는 데 있어 매우 중요합니다. 고령화와 이에 따른 수혈이 필요한 질환 증가와 같은 인구 통계학적 동향도 시장 확대에 크게 기여하고 있습니다. 또한, 헌혈자의 참여와 유지율을 높이기 위한 노력은 혈액 제제에 대한 수요 증가에 대응하는 데 필수적입니다. 일반 시민들에게 헌혈의 필요성과 이점에 대해 알리는 캠페인은 헌혈자 모집 전략의 강화와 더불어 안정적인 혈액 공급을 유지하는 데 필수적입니다. 또한, 신흥 경제국에서의 의료 인프라 확충으로 인해 혈액 제제가 필요한 의료 서비스에 대한 접근성이 향상되고 있으며, 이에 따라 시장이 확대되고 있습니다. 이러한 요인들은 수혈 의학 분야의 지속적인 연구 개발과 맞물려, 이 매우 중요한 분야의 강력한 성장을 지속적으로 견인하고 있습니다.

부문:

유형(혈장 유래 치료제, 전혈 및 혈액 성분), 용도(혈액학·종양학, 면역학·자가면역 질환, 지혈·응고 장애, 응급의료, 외과·수혈의학), 최종 용도(병원, 혈액은행, 전문 클리닉, 연구소)

주요 기업

  • AABB
  • Abbott Laboratories
  • American Red Cross
  • America's Blood Centers
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Beijing Tiantan Biological Products Co., Ltd.
  • Bharat Serums and Vaccines Ltd.
  • Bio Products Laboratory Ltd.
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Biotest AG
  • Canadian Blood Services
  • Cerus Corporation
  • China Biologic Products, Inc.
  • CSL Behring LLC
  • Fenwal Inc.
  • Fresenius Kabi AG
  • Grifols S.A.
  • Haemonetics Corporation
  • Immucor Inc.
  • Kawasumi Laboratories, Inc.
  • Kedrion S.p.A.
  • LFB Group
  • MacoPharma SA
  • New York Blood Center
  • Octapharma AG
  • Ortho-Clinical Diagnostics, Inc.
  • Shanghai RAAS Blood Products Co., Ltd.
  • Shire plc
  • Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
  • Terumo BCT Inc.

해당 분야의 전문가 관점을 바탕으로 합니다. 산업계, 기업, 학계에 걸친 분야 전문가들의 관점을 반영하여, 기존에 발표된 조사 결과 이상의 맥락을 더하고 있습니다.

시장의 초기 신호를 포착합니다 - 기존의 2차 조사에 완전히 반영되기 전에, 전문가 간의 대화, 기업의 동향, 시장과 관련된 논의를 통해 드러나는 변화를 추적합니다.

광범위하고 검증된 정보 기반을 활용합니다 - 컨퍼런스 세션, 기조 연설, 패널 토론, 블로그, 기업 공시 정보, 연차 보고서, 기관 간행물 및 기타 검증된 정보원에서 얻은 인사이트를 통합하고 있습니다.

신호와 전략적 시장 방향성을 연결합니다 - 이러한 관점을 통합하여 시장이 어디로 향하고 있는지, 그 움직임을 주도하는 요인은 무엇인지, 그리고 전략에 있어 가장 중요할 가능성이 있는 동향은 무엇인지 파악합니다.

상세한 기업 정보를 제공합니다 - 시장 수준의 분석에 그치지 않고, 경쟁 환경에 참여하며 그 형성에 기여하고 있는 기업을 상세하게 검증합니다.

주요 지역 시장 점유율을 면밀히 검토합니다 - 단일 세계 시장 점유율 수치만으로는 전체적인 상황을 파악하기 어렵습니다. 경쟁 구도는 지역에 따라 크게 다를 수 있습니다. 분석상 관련성이 있는 경우, Market Glass의 보고서는 각 시장의 구조와 동향에 맞추어 상세도를 조정하여 주요 지역 시장 점유율 분석을 심층적으로 다룹니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 26.10.29

Global Blood Banking and Blood Products Market to Reach US$42.7 Billion by 2032

The global market for Blood Banking and Blood Products estimated at US$33.6 Billion in the year 2025, is expected to reach US$42.7 Billion by 2032, growing at a CAGR of 3.5% over the analysis period 2025-2032. Plasma-derived Therapeutics Type, one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$26.0 Billion by the end of the analysis period. Growth in the Whole Blood & Blood Components Type segment is estimated at 4.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$9.2 Billion While China is Forecast to Grow at 5.9% CAGR

The Blood Banking and Blood Products market in the U.S. is estimated at US$9.2 Billion in the year 2025. China, the world's second largest economy, is forecast to reach a projected market size of US$8.4 Billion by the year 2032 trailing a CAGR of 5.9% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 2.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.2% CAGR.

Global Blood Banking and Blood Products Market - Key Trends and Drivers Summarized

How Does the Blood Banking System Sustain Public Health?

Blood banking, a critical component of modern healthcare systems, ensures the safe collection, storage, and distribution of blood and blood products necessary for medical procedures. This system involves not only the collection of whole blood from donors but also the processing of blood to obtain components like red cells, platelets, and plasma, which can be used individually to treat various conditions. Stringent regulatory standards govern every step of the process to minimize risks of transfusion-transmitted infections and ensure the safety and effectiveness of blood products. Blood banks also play a vital role in emergency preparedness by maintaining an adequate supply to meet routine and crisis-driven demands. The efficiency of blood banks in managing the supply chain-from donor recruitment to the final delivery of blood products to medical facilities-directly impacts their ability to save lives and improve patient outcomes.

What Technological Innovations Are Enhancing Blood Banking?

The field of blood banking has benefited significantly from technological advancements that enhance the safety, efficiency, and efficacy of blood product storage and transfusion. Automated systems for blood collection and processing have standardized many procedures, reducing human error and increasing the yield of viable blood components. Technologies such as pathogen reduction systems improve the safety of blood transfusions by inactivating potential contaminants that can cause infections. Moreover, sophisticated refrigeration and freezing equipment has extended the shelf life of blood products, allowing for better management of inventories and reduced waste. Data management systems integrate these technologies, providing real-time tracking and optimized logistics, ensuring that the right type of blood product is available when and where it is needed most.

How Are Regulatory Changes and Global Health Needs Shaping Blood Banking?

Regulatory frameworks and global health needs are constantly shaping practices within the blood banking industry. Changes in regulations often reflect advancements in medical research, emerging health threats, or shifts in public health policies. For example, responses to global pandemics or outbreaks necessitate rapid adjustments in blood collection practices and donor eligibility criteria to safeguard the blood supply. Additionally, international collaboration efforts are enhancing the standards of practice worldwide, aiming to elevate blood safety and availability in under-resourced regions. These efforts include training, the establishment of standardized protocols, and support for infrastructure development in blood banks, which are critical for addressing disparities in global health care and ensuring equitable access to life-saving blood products.

What Drives the Growth in the Blood Banking and Blood Products Market?

The growth in the blood banking and blood products market is driven by several factors, including technological advancements, increased awareness of the importance of blood donation, and rising global health care demands. Technological innovations that improve the efficiency of blood collection, processing, and storage are crucial, as they enhance the overall safety and availability of blood supplies. Demographic trends, such as aging populations and the consequent rise in medical conditions that require blood transfusions, also contribute significantly to market expansion. Additionally, initiatives aimed at increasing donor participation and retention have been vital in meeting the growing demand for blood products. Campaigns that educate the public about the need for and benefits of donating blood, coupled with enhanced donor recruitment strategies, are essential for maintaining a stable blood supply. Furthermore, expanding healthcare infrastructure in emerging economies is increasing access to medical treatments that require blood products, thereby broadening the market. These factors, combined with ongoing research and development in transfusion medicine, continue to drive the dynamic growth of this critical sector.

SCOPE OF STUDY:

The report analyzes the Blood Banking and Blood Products market by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Plasma-derived Therapeutics Type, Whole Blood & Blood Components Type); Application (Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application, Surgical & Transfusion Medicine Application); End-Use (Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use, Research Laboratories End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

SELECT PLAYERS -

  • AABB
  • Abbott Laboratories
  • American Red Cross
  • America's Blood Centers
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Beijing Tiantan Biological Products Co., Ltd.
  • Bharat Serums and Vaccines Ltd.
  • Bio Products Laboratory Ltd.
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Biotest AG
  • Canadian Blood Services
  • Cerus Corporation
  • China Biologic Products, Inc.
  • CSL Behring LLC
  • Fenwal Inc.
  • Fresenius Kabi AG
  • Grifols S.A.
  • Haemonetics Corporation
  • Immucor Inc.
  • Kawasumi Laboratories, Inc.
  • Kedrion S.p.A.
  • LFB Group
  • MacoPharma SA
  • New York Blood Center
  • Octapharma AG
  • Ortho-Clinical Diagnostics, Inc.
  • Shanghai RAAS Blood Products Co., Ltd.
  • Shire plc
  • Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
  • Terumo BCT Inc.

WHAT SETS THIS REPORT APART FROM OTHERS?

Grounded in Domain Expert Perspectives - Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.

Captures Early Market Signals - Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.

Draws From a Broad, Validated Intelligence Base - Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.

Connects Signals With Strategic Market Direction - Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.

Provides In-Depth Company Intelligence - Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.

Market Share Is Examined Where It Matters - A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, Market Glass reports extend market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Global Economic Update
    • Blood Banking and Blood Products - Global Key Competitors Percentage Market Share in 2026 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for 209 Players Worldwide in 2026 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Global Demand for Blood Due to Rising Surgical Procedures Expands Market Growth
    • Advances in Blood Storage and Preservation Technology Drive Market Growth
    • Growing Awareness of Blood Donation Benefits Strengthens the Blood Banking Sector
    • Integration of Automation in Blood Processing Throws the Spotlight On Efficiency
    • Development of Synthetic Blood Products Sets the Stage for New Market Opportunities
    • Challenges and Opportunities in Rare Blood Type Matching and Storage
    • Impact of Global Health Crises on Blood Supply and Blood Product Demand
    • Rising Prevalence of Chronic Diseases and the Role of Blood Products in Treatment
    • Demand for Plasma-derived Medicinal Products in Treating Rare Diseases
    • Global Health Initiatives Driving Improvements in Blood Safety Standards
    • The Increasing Use of Data Analytics for Blood Bank Management and Efficiency
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Blood Banking and Blood Products Market Analysis of Annual Sales in US$ Million for Years 2020 through 2032
    • TABLE 2: World Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 3: World Historic Review for Blood Banking and Blood Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 4: World 13-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
    • TABLE 5: World Recent Past, Current & Future Analysis for Plasma-derived Therapeutics Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 6: World Historic Review for Plasma-derived Therapeutics Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 7: World 13-Year Perspective for Plasma-derived Therapeutics Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 8: World Recent Past, Current & Future Analysis for Whole Blood & Blood Components Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 9: World Historic Review for Whole Blood & Blood Components Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 10: World 13-Year Perspective for Whole Blood & Blood Components Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 11: World Recent Past, Current & Future Analysis for Hematology & Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 12: World Historic Review for Hematology & Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 13: World 13-Year Perspective for Hematology & Oncology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 14: World Recent Past, Current & Future Analysis for Immunology & Autoimmune Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 15: World Historic Review for Immunology & Autoimmune Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 16: World 13-Year Perspective for Immunology & Autoimmune Disorders Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 17: World Recent Past, Current & Future Analysis for Hemostasis & Coagulation Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 18: World Historic Review for Hemostasis & Coagulation Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 19: World 13-Year Perspective for Hemostasis & Coagulation Disorders Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 20: World Recent Past, Current & Future Analysis for Critical Care & Emergency Medicine Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 21: World Historic Review for Critical Care & Emergency Medicine Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 22: World 13-Year Perspective for Critical Care & Emergency Medicine Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 23: World Recent Past, Current & Future Analysis for Surgical & Transfusion Medicine Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 24: World Historic Review for Surgical & Transfusion Medicine Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 25: World 13-Year Perspective for Surgical & Transfusion Medicine Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 26: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 27: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 28: World 13-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 29: World Recent Past, Current & Future Analysis for Blood Banks End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 30: World Historic Review for Blood Banks End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 31: World 13-Year Perspective for Blood Banks End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 32: World Recent Past, Current & Future Analysis for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 33: World Historic Review for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 34: World 13-Year Perspective for Specialty Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 35: World Recent Past, Current & Future Analysis for Research Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 36: World Historic Review for Research Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 37: World 13-Year Perspective for Research Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032

III. MARKET ANALYSIS

  • UNITED STATES
    • Blood Banking and Blood Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 39: USA Historic Review for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 40: USA 13-Year Perspective for Blood Banking and Blood Products by Type - Percentage Breakdown of Value Sales for Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type for the Years 2020, 2026 & 2032
    • TABLE 41: USA Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 42: USA Historic Review for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 43: USA 13-Year Perspective for Blood Banking and Blood Products by Application - Percentage Breakdown of Value Sales for Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application for the Years 2020, 2026 & 2032
    • TABLE 44: USA Recent Past, Current & Future Analysis for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 45: USA Historic Review for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 46: USA 13-Year Perspective for Blood Banking and Blood Products by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use for the Years 2020, 2026 & 2032
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 48: Canada Historic Review for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 49: Canada 13-Year Perspective for Blood Banking and Blood Products by Type - Percentage Breakdown of Value Sales for Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type for the Years 2020, 2026 & 2032
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 51: Canada Historic Review for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 52: Canada 13-Year Perspective for Blood Banking and Blood Products by Application - Percentage Breakdown of Value Sales for Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application for the Years 2020, 2026 & 2032
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 54: Canada Historic Review for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 55: Canada 13-Year Perspective for Blood Banking and Blood Products by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use for the Years 2020, 2026 & 2032
  • JAPAN
    • Blood Banking and Blood Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 57: Japan Historic Review for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 58: Japan 13-Year Perspective for Blood Banking and Blood Products by Type - Percentage Breakdown of Value Sales for Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type for the Years 2020, 2026 & 2032
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 60: Japan Historic Review for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 61: Japan 13-Year Perspective for Blood Banking and Blood Products by Application - Percentage Breakdown of Value Sales for Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application for the Years 2020, 2026 & 2032
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 63: Japan Historic Review for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 64: Japan 13-Year Perspective for Blood Banking and Blood Products by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use for the Years 2020, 2026 & 2032
  • CHINA
    • Blood Banking and Blood Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 66: China Historic Review for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 67: China 13-Year Perspective for Blood Banking and Blood Products by Type - Percentage Breakdown of Value Sales for Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type for the Years 2020, 2026 & 2032
    • TABLE 68: China Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 69: China Historic Review for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 70: China 13-Year Perspective for Blood Banking and Blood Products by Application - Percentage Breakdown of Value Sales for Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application for the Years 2020, 2026 & 2032
    • TABLE 71: China Recent Past, Current & Future Analysis for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 72: China Historic Review for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 73: China 13-Year Perspective for Blood Banking and Blood Products by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use for the Years 2020, 2026 & 2032
  • EUROPE
    • Blood Banking and Blood Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 75: Europe Historic Review for Blood Banking and Blood Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 76: Europe 13-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2020, 2026 & 2032
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 78: Europe Historic Review for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 79: Europe 13-Year Perspective for Blood Banking and Blood Products by Type - Percentage Breakdown of Value Sales for Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type for the Years 2020, 2026 & 2032
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 81: Europe Historic Review for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 82: Europe 13-Year Perspective for Blood Banking and Blood Products by Application - Percentage Breakdown of Value Sales for Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application for the Years 2020, 2026 & 2032
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 84: Europe Historic Review for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 85: Europe 13-Year Perspective for Blood Banking and Blood Products by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use for the Years 2020, 2026 & 2032
  • FRANCE
    • Blood Banking and Blood Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 87: France Historic Review for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 88: France 13-Year Perspective for Blood Banking and Blood Products by Type - Percentage Breakdown of Value Sales for Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type for the Years 2020, 2026 & 2032
    • TABLE 89: France Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 90: France Historic Review for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 91: France 13-Year Perspective for Blood Banking and Blood Products by Application - Percentage Breakdown of Value Sales for Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application for the Years 2020, 2026 & 2032
    • TABLE 92: France Recent Past, Current & Future Analysis for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 93: France Historic Review for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 94: France 13-Year Perspective for Blood Banking and Blood Products by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use for the Years 2020, 2026 & 2032
  • GERMANY
    • Blood Banking and Blood Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 96: Germany Historic Review for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 97: Germany 13-Year Perspective for Blood Banking and Blood Products by Type - Percentage Breakdown of Value Sales for Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type for the Years 2020, 2026 & 2032
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 99: Germany Historic Review for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 100: Germany 13-Year Perspective for Blood Banking and Blood Products by Application - Percentage Breakdown of Value Sales for Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application for the Years 2020, 2026 & 2032
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 102: Germany Historic Review for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 103: Germany 13-Year Perspective for Blood Banking and Blood Products by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use for the Years 2020, 2026 & 2032
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 105: Italy Historic Review for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 106: Italy 13-Year Perspective for Blood Banking and Blood Products by Type - Percentage Breakdown of Value Sales for Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type for the Years 2020, 2026 & 2032
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 108: Italy Historic Review for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 109: Italy 13-Year Perspective for Blood Banking and Blood Products by Application - Percentage Breakdown of Value Sales for Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application for the Years 2020, 2026 & 2032
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 111: Italy Historic Review for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 112: Italy 13-Year Perspective for Blood Banking and Blood Products by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use for the Years 2020, 2026 & 2032
  • UNITED KINGDOM
    • Blood Banking and Blood Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 114: UK Historic Review for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 115: UK 13-Year Perspective for Blood Banking and Blood Products by Type - Percentage Breakdown of Value Sales for Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type for the Years 2020, 2026 & 2032
    • TABLE 116: UK Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 117: UK Historic Review for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 118: UK 13-Year Perspective for Blood Banking and Blood Products by Application - Percentage Breakdown of Value Sales for Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application for the Years 2020, 2026 & 2032
    • TABLE 119: UK Recent Past, Current & Future Analysis for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 120: UK Historic Review for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 121: UK 13-Year Perspective for Blood Banking and Blood Products by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use for the Years 2020, 2026 & 2032
  • SPAIN
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 123: Spain Historic Review for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 124: Spain 13-Year Perspective for Blood Banking and Blood Products by Type - Percentage Breakdown of Value Sales for Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type for the Years 2020, 2026 & 2032
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 126: Spain Historic Review for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 127: Spain 13-Year Perspective for Blood Banking and Blood Products by Application - Percentage Breakdown of Value Sales for Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application for the Years 2020, 2026 & 2032
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 129: Spain Historic Review for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 130: Spain 13-Year Perspective for Blood Banking and Blood Products by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use for the Years 2020, 2026 & 2032
  • RUSSIA
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 132: Russia Historic Review for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 133: Russia 13-Year Perspective for Blood Banking and Blood Products by Type - Percentage Breakdown of Value Sales for Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type for the Years 2020, 2026 & 2032
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 135: Russia Historic Review for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 136: Russia 13-Year Perspective for Blood Banking and Blood Products by Application - Percentage Breakdown of Value Sales for Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application for the Years 2020, 2026 & 2032
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 138: Russia Historic Review for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 139: Russia 13-Year Perspective for Blood Banking and Blood Products by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use for the Years 2020, 2026 & 2032
  • REST OF EUROPE
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 142: Rest of Europe 13-Year Perspective for Blood Banking and Blood Products by Type - Percentage Breakdown of Value Sales for Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type for the Years 2020, 2026 & 2032
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 145: Rest of Europe 13-Year Perspective for Blood Banking and Blood Products by Application - Percentage Breakdown of Value Sales for Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application for the Years 2020, 2026 & 2032
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 148: Rest of Europe 13-Year Perspective for Blood Banking and Blood Products by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use for the Years 2020, 2026 & 2032
  • ASIA-PACIFIC
    • Blood Banking and Blood Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Blood Banking and Blood Products by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 151: Asia-Pacific 13-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2020, 2026 & 2032
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 154: Asia-Pacific 13-Year Perspective for Blood Banking and Blood Products by Type - Percentage Breakdown of Value Sales for Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type for the Years 2020, 2026 & 2032
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 157: Asia-Pacific 13-Year Perspective for Blood Banking and Blood Products by Application - Percentage Breakdown of Value Sales for Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application for the Years 2020, 2026 & 2032
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 160: Asia-Pacific 13-Year Perspective for Blood Banking and Blood Products by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use for the Years 2020, 2026 & 2032
  • AUSTRALIA
    • Blood Banking and Blood Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 162: Australia Historic Review for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 163: Australia 13-Year Perspective for Blood Banking and Blood Products by Type - Percentage Breakdown of Value Sales for Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type for the Years 2020, 2026 & 2032
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 165: Australia Historic Review for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 166: Australia 13-Year Perspective for Blood Banking and Blood Products by Application - Percentage Breakdown of Value Sales for Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application for the Years 2020, 2026 & 2032
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 168: Australia Historic Review for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 169: Australia 13-Year Perspective for Blood Banking and Blood Products by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use for the Years 2020, 2026 & 2032
  • INDIA
    • Blood Banking and Blood Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
    • TABLE 170: India Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 171: India Historic Review for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 172: India 13-Year Perspective for Blood Banking and Blood Products by Type - Percentage Breakdown of Value Sales for Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type for the Years 2020, 2026 & 2032
    • TABLE 173: India Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 174: India Historic Review for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 175: India 13-Year Perspective for Blood Banking and Blood Products by Application - Percentage Breakdown of Value Sales for Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application for the Years 2020, 2026 & 2032
    • TABLE 176: India Recent Past, Current & Future Analysis for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 177: India Historic Review for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 178: India 13-Year Perspective for Blood Banking and Blood Products by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use for the Years 2020, 2026 & 2032
  • SOUTH KOREA
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 180: South Korea Historic Review for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 181: South Korea 13-Year Perspective for Blood Banking and Blood Products by Type - Percentage Breakdown of Value Sales for Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type for the Years 2020, 2026 & 2032
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 183: South Korea Historic Review for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 184: South Korea 13-Year Perspective for Blood Banking and Blood Products by Application - Percentage Breakdown of Value Sales for Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application for the Years 2020, 2026 & 2032
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 186: South Korea Historic Review for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 187: South Korea 13-Year Perspective for Blood Banking and Blood Products by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use for the Years 2020, 2026 & 2032
  • REST OF ASIA-PACIFIC
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 13-Year Perspective for Blood Banking and Blood Products by Type - Percentage Breakdown of Value Sales for Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type for the Years 2020, 2026 & 2032
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 13-Year Perspective for Blood Banking and Blood Products by Application - Percentage Breakdown of Value Sales for Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application for the Years 2020, 2026 & 2032
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 13-Year Perspective for Blood Banking and Blood Products by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use for the Years 2020, 2026 & 2032
  • LATIN AMERICA
    • Blood Banking and Blood Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 198: Latin America Historic Review for Blood Banking and Blood Products by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 199: Latin America 13-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2020, 2026 & 2032
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 201: Latin America Historic Review for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 202: Latin America 13-Year Perspective for Blood Banking and Blood Products by Type - Percentage Breakdown of Value Sales for Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type for the Years 2020, 2026 & 2032
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 204: Latin America Historic Review for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 205: Latin America 13-Year Perspective for Blood Banking and Blood Products by Application - Percentage Breakdown of Value Sales for Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application for the Years 2020, 2026 & 2032
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 207: Latin America Historic Review for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 208: Latin America 13-Year Perspective for Blood Banking and Blood Products by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use for the Years 2020, 2026 & 2032
  • ARGENTINA
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 210: Argentina Historic Review for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 211: Argentina 13-Year Perspective for Blood Banking and Blood Products by Type - Percentage Breakdown of Value Sales for Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type for the Years 2020, 2026 & 2032
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 213: Argentina Historic Review for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 214: Argentina 13-Year Perspective for Blood Banking and Blood Products by Application - Percentage Breakdown of Value Sales for Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application for the Years 2020, 2026 & 2032
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 216: Argentina Historic Review for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 217: Argentina 13-Year Perspective for Blood Banking and Blood Products by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use for the Years 2020, 2026 & 2032
  • BRAZIL
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 219: Brazil Historic Review for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 220: Brazil 13-Year Perspective for Blood Banking and Blood Products by Type - Percentage Breakdown of Value Sales for Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type for the Years 2020, 2026 & 2032
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 222: Brazil Historic Review for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 223: Brazil 13-Year Perspective for Blood Banking and Blood Products by Application - Percentage Breakdown of Value Sales for Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application for the Years 2020, 2026 & 2032
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 225: Brazil Historic Review for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 226: Brazil 13-Year Perspective for Blood Banking and Blood Products by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use for the Years 2020, 2026 & 2032
  • MEXICO
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 228: Mexico Historic Review for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 229: Mexico 13-Year Perspective for Blood Banking and Blood Products by Type - Percentage Breakdown of Value Sales for Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type for the Years 2020, 2026 & 2032
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 231: Mexico Historic Review for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 232: Mexico 13-Year Perspective for Blood Banking and Blood Products by Application - Percentage Breakdown of Value Sales for Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application for the Years 2020, 2026 & 2032
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 234: Mexico Historic Review for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 235: Mexico 13-Year Perspective for Blood Banking and Blood Products by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use for the Years 2020, 2026 & 2032
  • REST OF LATIN AMERICA
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 238: Rest of Latin America 13-Year Perspective for Blood Banking and Blood Products by Type - Percentage Breakdown of Value Sales for Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type for the Years 2020, 2026 & 2032
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 241: Rest of Latin America 13-Year Perspective for Blood Banking and Blood Products by Application - Percentage Breakdown of Value Sales for Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application for the Years 2020, 2026 & 2032
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 244: Rest of Latin America 13-Year Perspective for Blood Banking and Blood Products by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use for the Years 2020, 2026 & 2032
  • MIDDLE EAST
    • Blood Banking and Blood Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 246: Middle East Historic Review for Blood Banking and Blood Products by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 247: Middle East 13-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2020, 2026 & 2032
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 249: Middle East Historic Review for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 250: Middle East 13-Year Perspective for Blood Banking and Blood Products by Type - Percentage Breakdown of Value Sales for Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type for the Years 2020, 2026 & 2032
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 252: Middle East Historic Review for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 253: Middle East 13-Year Perspective for Blood Banking and Blood Products by Application - Percentage Breakdown of Value Sales for Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application for the Years 2020, 2026 & 2032
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 255: Middle East Historic Review for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 256: Middle East 13-Year Perspective for Blood Banking and Blood Products by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use for the Years 2020, 2026 & 2032
  • IRAN
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 258: Iran Historic Review for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 259: Iran 13-Year Perspective for Blood Banking and Blood Products by Type - Percentage Breakdown of Value Sales for Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type for the Years 2020, 2026 & 2032
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 261: Iran Historic Review for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 262: Iran 13-Year Perspective for Blood Banking and Blood Products by Application - Percentage Breakdown of Value Sales for Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application for the Years 2020, 2026 & 2032
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 264: Iran Historic Review for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 265: Iran 13-Year Perspective for Blood Banking and Blood Products by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use for the Years 2020, 2026 & 2032
  • ISRAEL
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 267: Israel Historic Review for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 268: Israel 13-Year Perspective for Blood Banking and Blood Products by Type - Percentage Breakdown of Value Sales for Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type for the Years 2020, 2026 & 2032
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 270: Israel Historic Review for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 271: Israel 13-Year Perspective for Blood Banking and Blood Products by Application - Percentage Breakdown of Value Sales for Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application for the Years 2020, 2026 & 2032
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 273: Israel Historic Review for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 274: Israel 13-Year Perspective for Blood Banking and Blood Products by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use for the Years 2020, 2026 & 2032
  • SAUDI ARABIA
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 277: Saudi Arabia 13-Year Perspective for Blood Banking and Blood Products by Type - Percentage Breakdown of Value Sales for Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type for the Years 2020, 2026 & 2032
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 280: Saudi Arabia 13-Year Perspective for Blood Banking and Blood Products by Application - Percentage Breakdown of Value Sales for Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application for the Years 2020, 2026 & 2032
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 283: Saudi Arabia 13-Year Perspective for Blood Banking and Blood Products by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use for the Years 2020, 2026 & 2032
  • UNITED ARAB EMIRATES
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 285: UAE Historic Review for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 286: UAE 13-Year Perspective for Blood Banking and Blood Products by Type - Percentage Breakdown of Value Sales for Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type for the Years 2020, 2026 & 2032
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 288: UAE Historic Review for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 289: UAE 13-Year Perspective for Blood Banking and Blood Products by Application - Percentage Breakdown of Value Sales for Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application for the Years 2020, 2026 & 2032
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 291: UAE Historic Review for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 292: UAE 13-Year Perspective for Blood Banking and Blood Products by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use for the Years 2020, 2026 & 2032
  • REST OF MIDDLE EAST
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 295: Rest of Middle East 13-Year Perspective for Blood Banking and Blood Products by Type - Percentage Breakdown of Value Sales for Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type for the Years 2020, 2026 & 2032
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 298: Rest of Middle East 13-Year Perspective for Blood Banking and Blood Products by Application - Percentage Breakdown of Value Sales for Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application for the Years 2020, 2026 & 2032
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 301: Rest of Middle East 13-Year Perspective for Blood Banking and Blood Products by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use for the Years 2020, 2026 & 2032
  • AFRICA
    • Blood Banking and Blood Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 303: Africa Historic Review for Blood Banking and Blood Products by Type - Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 304: Africa 13-Year Perspective for Blood Banking and Blood Products by Type - Percentage Breakdown of Value Sales for Plasma-derived Therapeutics Type and Whole Blood & Blood Components Type for the Years 2020, 2026 & 2032
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 306: Africa Historic Review for Blood Banking and Blood Products by Application - Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 307: Africa 13-Year Perspective for Blood Banking and Blood Products by Application - Percentage Breakdown of Value Sales for Hematology & Oncology Application, Immunology & Autoimmune Disorders Application, Hemostasis & Coagulation Disorders Application, Critical Care & Emergency Medicine Application and Surgical & Transfusion Medicine Application for the Years 2020, 2026 & 2032
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 309: Africa Historic Review for Blood Banking and Blood Products by End-Use - Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 310: Africa 13-Year Perspective for Blood Banking and Blood Products by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Blood Banks End-Use, Specialty Clinics End-Use and Research Laboratories End-Use for the Years 2020, 2026 & 2032

IV. COMPETITION

×

원하시는 정보를 찾아 드릴까요?

보안문자 새로고침
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기